TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21976055

Group type: EXPERIMENTAL
Intervention: Dose-dense albumin-bound paclitaxel (ab-P) 260 mg/m²
Number of subjects: 197

Group type: COMPARATOR
Intervention: Cremophor-formulated paclitaxel (cf-P) 175 mg/m² plus bevacizumab
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Dose-dense doxorubicin (A) 60 mg/m² plus cyclophosphamide (C) 600 mg/m²
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Dose-dense albumin-bound paclitaxel (ab-P)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Cremophor-formulated paclitaxel (cf-P)
Number of subjects: 197
Study: 18316163

Group type: EXPERIMENTAL
Intervention: Garcinia cambogia extract (1667.3 mg/day equivalent to 1000 mg HCA/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 16490088

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask (LMA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laryngeal Tube (LT)
Number of subjects: 30
Study: 12592084

Group type: EXPERIMENTAL
Intervention: 70% maize-oil-dissolved oral CsA solution
Number of subjects: 16

Group type: COMPARATOR
Intervention: Maize oil alone
Number of subjects: 16
Study: 10846030

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (HCD; approximately 78% carbohydrate)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Moderate-carbohydrate diet (MD; approximately 48% carbohydrate)
Number of subjects: 6
Study: 9339943

Group type: EXPERIMENTAL
Intervention: Immediate postoperative enteral feeding via jejunostomy (fed group)
Number of subjects: 28
Study: 8416449

Group type: EXPERIMENTAL
Intervention: Local anesthesia with IV sedation (lidocaine with adrenaline, bupivacaine, midazolam, alfentanil)
Number of subjects: 125

Group type: COMPARATOR
Intervention: General anesthesia (alfentanil, propofol, atracurium)
Number of subjects: 125
Study: 3709032

Group type: EXPERIMENTAL
Intervention: Pentazocine HCl 40 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pentazocine HCl 80 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Tripelennamine HCl 50 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Tripelennamine HCl 100 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Pentazocine with Tripelennamine
Number of subjects: 6
Study: 30062941

Group type: EXPERIMENTAL
Intervention: Cemented femoral stem
Number of subjects: 141

Group type: COMPARATOR
Intervention: Cementless femoral stem
Number of subjects: 141
Study: 26869182

Group type: EXPERIMENTAL
Intervention: Body psychotherapy group (10-week, 90-minute, 20-session manualised group body psychotherapy)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Body psychotherapy group
Number of subjects: 275

Group type: COMPARATOR
Intervention: Pilates group (10-week, 90-minute, 20-session group beginners' Pilates class)
Number of subjects: 275
Study: 26201718

Group type: EXPERIMENTAL
Intervention: Non-sedation supplemented with pain management during mechanical ventilation
Number of subjects: 700

Group type: COMPARATOR
Intervention: Sedation with a daily wake-up trial
Number of subjects: 700
Study: 23054212

Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg/day plus Lapatinib 1,500 mg/day
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Pazopanib 400 mg/day plus Lapatinib 1,000 mg/day
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Pazopanib and Lapatinib combination therapy
Number of subjects: 75
Study: 20875756

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl + EDTA with gutta‐percha/AH26
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.3% NaOCl + MTAD with gutta‐percha/AH26
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resilon/Epiphany SE
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gutta‐percha/AH26
Number of subjects: 0
Study: 18433009

Group type: EXPERIMENTAL
Intervention: Bioactive glass (BG)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Autogenous bone (AB)
Number of subjects: 25
Study: 17170773

Group type: EXPERIMENTAL
Intervention: TX-disc shielding against earth rays
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no TX-disc shielding)
Number of subjects: 80
Study: 12438058

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine 0.025 mmol/kg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine 0.05 mmol/kg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine 0.1 mmol/kg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine 0.2 mmol/kg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced MR angiography
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: All doses of gadobenate dimeglumine
Number of subjects: 94
Study: 10326702

Group type: EXPERIMENTAL
Intervention: Cisplatin-based polychemotherapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cisplatin-based polychemotherapy + IL-12 incubation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cisplatin-based polychemotherapy + Amifostine pretreatment
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cisplatin-based polychemotherapy + Amifostine pretreatment + IL-12 incubation
Number of subjects: 21
Study: 8606613

Group type: EXPERIMENTAL
Intervention: D2 resection (levels 1 and 2 lymphadenectomy)
Number of subjects: 400

Group type: COMPARATOR
Intervention: D1 resection (level 1 lymphadenectomy)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: D2 resection with en-bloc pancreatico-splenic resection
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Other patients (not undergoing en-bloc pancreatico-splenic resection)
Number of subjects: 400
Study: 2029709

Group type: EXPERIMENTAL
Intervention: Dipyridamole 200 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dipyridamole 200 mg plus Aspirin 300 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7028897

Group type: EXPERIMENTAL
Intervention: S-carboxymethylcysteine syrup (SCMC)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Brompheniramine, phenylephrine with phenylpropanolamine elixir (BPP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 28942681

Group type: EXPERIMENTAL
Intervention: Disability Rating Scale (three-factor structure)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Disability Rating Scale (Factor 1: disability items)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Disability Rating Scale (Factor 2: impairment items)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Disability Rating Scale (Factor 3: handicap items)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Impairment factor at admission
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Disability factor at discharge
Number of subjects: 508
Study: 27981738

Group type: EXPERIMENTAL
Intervention: Atrasentan 0.75 mg/d
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Atrasentan 1.25 mg/d
Number of subjects: 211

Group type: COMPARATOR
Intervention: Atrasentan
Number of subjects: 211
Study: 25664993

Group type: EXPERIMENTAL
Intervention: Therapeutic shoulder strapping
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo shoulder strapping
Number of subjects: 17
Study: 24330220

Group type: EXPERIMENTAL
Intervention: Enhanced enrollment and engagement outreach (EEE)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Administrative outreach (AO)
Number of subjects: 203
Study: 22850358

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine
Number of subjects: 1904

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1904

Group type: EXPERIMENTAL
Intervention: Other antimalarial drugs
Number of subjects: 1904
Study: 19675863

Group type: EXPERIMENTAL
Intervention: Levocetirizine 5mg/day for 4 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 67

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 67
Study: 17276188

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents
Number of subjects: 1230

Group type: COMPARATOR
Intervention: Balloon angioplasty or vascular brachytherapy
Number of subjects: 1230
Study: 11271859

Group type: EXPERIMENTAL
Intervention: Canola oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High oleic sunflower oil (HOSO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Palmolein
Number of subjects: 0
Study: 9201799

Group type: EXPERIMENTAL
Intervention: abecarnil
Number of subjects: 49

Group type: COMPARATOR
Intervention: diazepam
Number of subjects: 49
Study: 1493085

Group type: EXPERIMENTAL
Intervention: AH 21-132 (20 mg, 40 mg) infused intravenously over 15 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AH 21-132 (2 mg to 24 mg) nebulized and inhaled
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled, nebulized hypertonic sucrose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AH 21-132 (intravenous and inhaled routes)
Number of subjects: 0
Study: 2861620

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zimelidine
Number of subjects: 0
Study: 31070986

Group type: EXPERIMENTAL
Intervention: IVACFLU-S (15 mcg hemagglutinin per strain)
Number of subjects: 888

Group type: EXPERIMENTAL
Intervention: IVACFLU-S
Number of subjects: 888

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 888
Study: 29797109

Group type: EXPERIMENTAL
Intervention: PG/timolol fixed combination therapy (switched group)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Adding topical ripasudil therapy (added group)
Number of subjects: 51
Study: 26688294

Group type: EXPERIMENTAL
Intervention: Lateral osteotomy performed in a horizontal straight fashion (Group 1, n = 16)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lateral osteotomy performed in parallel to the occlusal plane with a step at the zygomatic buttress (Group 2, n = 14)
Number of subjects: 30
Study: 24446825

Group type: EXPERIMENTAL
Intervention: Information about insect type
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Information about contamination processes
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Information about the safety of contaminated food
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Combinations of information types (2 of 1, 2, and 3)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: All information
Number of subjects: 320

Group type: COMPARATOR
Intervention: No information
Number of subjects: 320
Study: 22368259

Group type: EXPERIMENTAL
Intervention: Oil drops containing Lactobacillus salivarius WB21
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 20237213

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 18446440

Group type: EXPERIMENTAL
Intervention: Face-to-face groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-based sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Booklet only
Number of subjects: 0
Study: 15733195

Group type: EXPERIMENTAL
Intervention: Teaching about stereotype threat in a math test context
Number of subjects: 0

Group type: COMPARATOR
Intervention: Math test without discussion of stereotype threat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Problem-solving task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teaching about stereotype threat
Number of subjects: 0
Study: 14632722

Group type: EXPERIMENTAL
Intervention: High mix (HM) [75% lispro (LP) and 25% neutral protamine lispro (NPL)]
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin lispro (LP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High mix (HM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular human insulin (HR)
Number of subjects: 0
Study: 10570423

Group type: EXPERIMENTAL
Intervention: Indwelling pleural catheter
Number of subjects: 144

Group type: COMPARATOR
Intervention: Doxycycline pleurodesis
Number of subjects: 144
Study: 8547676

Group type: EXPERIMENTAL
Intervention: Busulfan (16 mg/kg) and cyclophosphamide (120 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cyclophosphamide and total body irradiation (historical control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Busulfan and cyclophosphamide (combined data)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Busulfan and cyclophosphamide (for patients aged 40 to 55 years)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Busulfan and cyclophosphamide (for patients receiving unrelated or mismatched related donor marrow)
Number of subjects: 30
Study: 1857992

Group type: EXPERIMENTAL
Intervention: Saxon test
Number of subjects: 47

Group type: COMPARATOR
Intervention: Chewing gum test
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both tests
Number of subjects: 47
Study: 29978257

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST) - hack-squat performed three times a week for 12 weeks at 90% of one repetition maximum (1RM)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CG) - conventional clinical treatment without MST
Number of subjects: 23
Study: 27774921

Group type: EXPERIMENTAL
Intervention: Castellani's paint
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Steroid ear drops
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Non-impacted cerumen removal
Number of subjects: 61
Study: 24335695

Group type: EXPERIMENTAL
Intervention: Dose-Intensive (DI) chemotherapy (Regimen B, n = 166)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Standard dose chemotherapy (Regimen A, n = 162)
Number of subjects: 328
Study: 23393711

Group type: EXPERIMENTAL
Intervention: Intensive intermittent physical therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard physical therapy
Number of subjects: 10
Study: 20862944

Group type: EXPERIMENTAL
Intervention: Acupuncture-drug compound anesthesia (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simple general anesthesia (Group B)
Number of subjects: 30
Study: 18678300

Group type: EXPERIMENTAL
Intervention: P-OM3 + simvastatin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo + simvastatin
Number of subjects: 39
Study: 15950852

Group type: COMPARATOR
Intervention: Eyelid group (n = 30) with TOF stimulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Eyelid group (n = 30) with DBS(3,3) stimulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Eyelid group (n = 30) with DBS(3,2) stimulation
Number of subjects: 60
Study: 12915664

Group type: EXPERIMENTAL
Intervention: 280-kCal preload
Number of subjects: 24

Group type: COMPARATOR
Intervention: No preload
Number of subjects: 24
Study: 16329539

Group type: EXPERIMENTAL
Intervention: Polyurethane filter
Number of subjects: 51

Group type: COMPARATOR
Intervention: Non-woven polyester filter
Number of subjects: 51
Study: 8889400

Group type: EXPERIMENTAL
Intervention: Cocaine dependence
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Alcohol dependence
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nicotine dependence
Number of subjects: 50
Study: 2058190

Group type: EXPERIMENTAL
Intervention: Bayesian method
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Chiou method
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Pediatric dosing algorithm
Number of subjects: 34
Study: 6683463

Group type: EXPERIMENTAL
Intervention: Amrinone, 100 mg orally every 8 hours for 1 month
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional CHF medications alone
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 13
Study: 30681720

Group type: EXPERIMENTAL
Intervention: Pharmacological management of delirium (PMD) bundle
Number of subjects: 351

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 351
Study: 28752695

Group type: EXPERIMENTAL
Intervention: 3% diquafosol ophthalmic solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 30
Study: 26927209

Group type: EXPERIMENTAL
Intervention: Personalised 3-month course of Occupational Therapy (OT) delivered by qualified therapists.
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Usual care for residents (Control).
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Occupational Therapy intervention for residents with stroke living in UK Care Homes.
Number of subjects: 1042
Study: 24465030

Group type: EXPERIMENTAL
Intervention: GSTP1 rs1138272 minor allele carriers
Number of subjects: 5115

Group type: EXPERIMENTAL
Intervention: GSTP1 rs1695 minor allele carriers
Number of subjects: 5115

Group type: COMPARATOR
Intervention: Homozygous major allele carriers (for GSTP1 rs1138272)
Number of subjects: 5115

Group type: COMPARATOR
Intervention: Homozygous major allele carriers (for GSTP1 rs1695)
Number of subjects: 5115

Group type: EXPERIMENTAL
Intervention: TNF genotype
Number of subjects: 5115
Study: 21423036

Group type: EXPERIMENTAL
Intervention: Silicone Ahmed glaucoma valve implant with intravitreal triamcinolone acetonide
Number of subjects: 49

Group type: COMPARATOR
Intervention: Silicone Ahmed glaucoma valve
Number of subjects: 49
Study: 19903345

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention consisting of three visits to a Personal Vitality Coach (PVC) and a Vitality Exercise Programme (VEP) over 6 months, including weekly guided yoga and aerobic workout sessions, and encouragement for vigorous physical activity.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract).
Number of subjects: 36
Study: 17396398

Group type: EXPERIMENTAL
Intervention: Alcoholic beverage (0.04 blood alcohol content)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 42
Study: 16243088

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 422

Group type: COMPARATOR
Intervention: Amphotericin B followed by fluconazole
Number of subjects: 422
Study: 12045644

Group type: EXPERIMENTAL
Intervention: Fluid resuscitation targeting SBP of 70 mm Hg (low)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Fluid resuscitation targeting SBP > 100 mm Hg (conventional)
Number of subjects: 110
Study: 9459231

Group type: EXPERIMENTAL
Intervention: Desflurane 2%-6%
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sevoflurane 0.6%-1.75%
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol 50-150 microg x kg(‐1) x min(‐1)
Number of subjects: 120
Study: 8527264

Group type: EXPERIMENTAL
Intervention: Metoprolol (4 mg)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Sotalol (20 mg)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Milrinone (1 mg)
Number of subjects: 35
Study: 2508009

Group type: EXPERIMENTAL
Intervention: In vitro food specific IgE tests
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: IgG radioallergosorbent tests
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Food enzyme-linked immune complex assays
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: In vivo Multi-Test prick tests
Number of subjects: 37

Group type: COMPARATOR
Intervention: Oral challenge food test (OCFT)
Number of subjects: 37
Study: 69191

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen as an adjuvant in radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Air (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiotherapy (3500 rads in 10 fractions over 3 weeks)
Number of subjects: 0
Study: 31094434

Group type: EXPERIMENTAL
Intervention: Couple-based intervention (6-session, telephone-based intervention)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Education control
Number of subjects: 21
Study: 27647376

Group type: EXPERIMENTAL
Intervention: Diaphragmatic ultrasound (US) measuring maximal diaphragmatic excursion (MDE)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Medical Research Council (MRC) score
Number of subjects: 67
Study: 25083980

Group type: EXPERIMENTAL
Intervention: Pyridoxalated hemoglobin polyoxyethylene (20 mg Hb/kg/hr)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Pyridoxalated hemoglobin polyoxyethylene
Number of subjects: 377
Study: 23412099

Group type: EXPERIMENTAL
Intervention: Docetaxel 30 mg/m² on days 1 and 8, every 3 weeks and cetuximab 400 mg/m² on day 1, then 250 mg/m² weekly
Number of subjects: 38
Study: 21330006

Group type: EXPERIMENTAL
Intervention: Routine A (culture of all tips)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Routine B (culture only of tips from patients with concomitant bacteraemia or fungaemia)
Number of subjects: 640
Study: 19377384

Group type: COMPARATOR
Intervention: DES
Number of subjects: 375

Group type: COMPARATOR
Intervention: Prednisone treatment (40-day after BMS implantation)
Number of subjects: 375

Group type: COMPARATOR
Intervention: BMS
Number of subjects: 375
Study: 17098084

Group type: EXPERIMENTAL
Intervention: 5 mg/day rimonabant
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: 20 mg/day rimonabant
Number of subjects: 1047

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1047
Study: 15446643

Group type: EXPERIMENTAL
Intervention: Experimental backpack
Number of subjects: 19

Group type: COMPARATOR
Intervention: Personal traditional backpacks
Number of subjects: 19
Study: 11760591

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intra-uterine system (levonorgestrel IUS; Mirena)
Number of subjects: 0
Study: 9521264

Group type: EXPERIMENTAL
Intervention: Immediate withdrawal of AEDs (n = 78)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Continuation of treatment for another 6 months followed by withdrawal (n = 83)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 161
Study: 7868437

Group type: EXPERIMENTAL
Intervention: Vitamin E (1,000 IU/day)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (before vitamin E supplementation)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (after vitamin E supplementation)
Number of subjects: 7
Study: 2807448

Group type: EXPERIMENTAL
Intervention: Oral rehydration therapy (ORT) introduced by health workers
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Oral rehydration therapy (ORT) introduced by health volunteers
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Oral rehydration therapy (ORT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no ORT)
Number of subjects: 200
Study: 781965

Group type: EXPERIMENTAL
Intervention: PAS plus isoniazid daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Streptomycin plus isoniazid twice a week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Streptomycin plus isoniazid twice a week for 1 year, then once a week
Number of subjects: 0